Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotype
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotype
Authors
Keywords
-
Journal
NEURO-ONCOLOGY
Volume 14, Issue 11, Pages 1379-1392
Publisher
Oxford University Press (OUP)
Online
2012-09-11
DOI
10.1093/neuonc/nos158
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Myeloid Biomarkers Associated with Glioblastoma Response to Anti-VEGF Therapy with Aflibercept
- (2011) J. F. de Groot et al. CLINICAL CANCER RESEARCH
- Bevacizumab and Irinotecan in the Treatment of Recurrent Malignant Gliomas
- (2010) John F. de Groot et al. CANCER JOURNAL
- Vascular Endothelial Growth Factor--A Positive and Negative Regulator of Tumor Growth
- (2010) L. M. Vecchiarelli-Federico et al. CANCER RESEARCH
- Complementary Actions of Inhibitors of Angiopoietin-2 and VEGF on Tumor Angiogenesis and Growth
- (2010) H. Hashizume et al. CANCER RESEARCH
- TWIST activation by hypoxia inducible factor-1 (HIF-1): Implications in metastasis and development
- (2010) Muh-Hwa Yang et al. CELL CYCLE
- Hypoxia and Hypoxia-Inducible Factors: Master Regulators of Metastasis
- (2010) X. Lu et al. CLINICAL CANCER RESEARCH
- Phase II study of sunitinib malate in patients with recurrent high-grade glioma
- (2010) B. Neyns et al. JOURNAL OF NEURO-ONCOLOGY
- Reversible Epithelial to Mesenchymal Transition and Acquired Resistance to Sunitinib in Patients with Renal Cell Carcinoma: Evidence from a Xenograft Study
- (2010) H. J. Hammers et al. MOLECULAR CANCER THERAPEUTICS
- Ongoing Clinical Trials
- (2010) J. L. Clarke et al. NEURO-ONCOLOGY
- Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
- (2009) John M.L. Ebos et al. CANCER CELL
- Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
- (2009) Marta Pàez-Ribes et al. CANCER CELL
- Mediators of Glioblastoma Resistance and Invasion during Antivascular Endothelial Growth Factor Therapy
- (2009) A. K. Lucio-Eterovic et al. CLINICAL CANCER RESEARCH
- "Antimyeloangiogenic" Therapy for Cancer by Inhibiting PlGF
- (2009) S. Loges et al. CLINICAL CANCER RESEARCH
- HIF2α cooperates with RAS to promote lung tumorigenesis in mice
- (2009) William Y. Kim et al. JOURNAL OF CLINICAL INVESTIGATION
- Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
- (2009) Henry S. Friedman et al. JOURNAL OF CLINICAL ONCOLOGY
- VEGFR1-activity-independent metastasis formation
- (2009) Michelle R. Dawson et al. NATURE
- VEGFR1 Activity Modulates Myeloid Cell Infiltration in Growing Lung Metastases but Is Not Required for Spontaneous Metastasis Formation
- (2009) Michelle R. Dawson et al. PLoS One
- G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models
- (2009) F. Shojaei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HIF1α Induces the Recruitment of Bone Marrow-Derived Vascular Modulatory Cells to Regulate Tumor Angiogenesis and Invasion
- (2008) Rose Du et al. CANCER CELL
- Flt-1 Signaling in Macrophages Promotes Glioma Growth In vivo
- (2008) M. Kerber et al. CANCER RESEARCH
- Differential effect of sunitinib on the distribution of temozolomide in an orthotopic glioma model
- (2008) Qingyu Zhou et al. NEURO-ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now